Vergleich von Splenektomie und immunsuppressiver Therapie bei M. Werlhof

  • J. C. F. Schubert
  • K. Breddin
  • H. Martin

Splenectomy and Immunosuppressive Therapy in Idiopathic Thrombocytopenic Purpura

Summary

20 patients with ITP were submitted to immunosuppressive treatment. The results were compared with the data from a group of 18 patients with ITP who were treated by splenectomy.

Splenectomy was performed when there was evidence for platelet destruction by the spleen. Immunosuppressive treatment was restricted to the cases with platelet sequestration in the liver and to patients where splenectomy was not possible.

As immunosuppressive agent we preferred actinomycin C: in ten cases we obtained an extensive remission after an average total dose of 11.9 mg actinomycin C. In four cases actinomycin therapy was not effective.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aster, R. H., Keene, W. R.: Sites of platelet destruction in idiopathic thrombocytopenic purpura. Brit. J. Haemat. 16, 61–73 (1969).PubMedCrossRefGoogle Scholar
  2. Bernard, J., Meshaka, G., Larrieu, M. J.: Les purpuras thrombopéniques mortels. Sem. Hop. Paris 40, 283–293 (1964).PubMedGoogle Scholar
  3. Bonnini, J. A.: The management of thrombocytopenic states with particular reference to platelet thromboplastic function. I. Idiopathic and secondary thrombocytopenic purpura. Brit. J. Haemat. 7, 250–260 (1961).CrossRefGoogle Scholar
  4. Bouroncle, B. A., Doan, C. A.: Treatment of refractory idiopathic thrombocytopenic purpura. Ann. intern. Med. 68, 1164 (1968).Google Scholar
  5. Doan, C. A., Bouroncle, B. A., Wiseman, B. K.: Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann. intern. Med. 53, 861–876 (1960).Google Scholar
  6. Larrieu, M. J., Meshaka, G., Caen, J., Bernard, J.: traitement di purpura thrombo- pénique idiopathique. Sem. Hop. Paris 40, 403–411 (1964).PubMedGoogle Scholar
  7. Martin, H., Nowicki, L., Schubert, J. C. F., Schubert, H.: Behandlung des Morbus Werlhof mit Actinomycin C. Dtsch. med. Wschr. 92, 1061–1065 (1967).PubMedCrossRefGoogle Scholar
  8. Solomon, R. B., Clatanoff, D. V.: Platelet survival studies and body scanning in idiopathic thrombocytopenic purpura. Amer. J. med. Sci. 254, 777–784 (1967).PubMedCrossRefGoogle Scholar
  9. Sprague, C. C, Harrington, W. J., Lange, R. D.: Platelet transfusions and the pathogenesis of idiopathic thrombocytopenic purpura. J. Amer. med. Ass. 150, 1193–1198 (1952).CrossRefGoogle Scholar
  10. Stefanini, M.: Management of thrombocytopenic states. Arch, intern. Med. 95, 543–556 (1965).Google Scholar
  11. Sussman, L. N.: Azathioprine in refractory idiopathic thrombocytopenic purpura. J. Amer. med. Ass. 202, 259–263 (1967).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1970

Authors and Affiliations

  • J. C. F. Schubert
  • K. Breddin
  • H. Martin
    • 1
  1. 1.Abteilung für Hämatologie des Zentrums der Inneren MedizinJ. W. Goethe-UniversitätFrankfurt a. M.Deutschland

Personalised recommendations